Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Novonesis

354.30 DKK

+1.66 %

Less than 1K followers

NSIS B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Novonesis

2019202020212022202320242025
Revenue14,374.014,012.014,951.017,553.017,899.028,589.431,050.2
growth-%-2.5 %6.7 %17.4 %2.0 %59.7 %8.6 %
EBITDA5,221.04,918.05,423.06,046.05,365.09,659.311,525.8
EBIT4,039.03,652.04,007.04,561.03,976.03,736.46,099.4
Profit before taxes3,799.03,521.03,924.04,556.03,909.03,110.65,600.5
Net income3,155.02,826.03,145.03,686.03,039.02,280.64,358.5
EPS10.9710.0211.3213.2910.925.009.34
Dividend5.255.255.506.006.204.184.25
Dividend ratio47.9 %52.4 %48.6 %45.1 %56.8 %83.6 %45.5 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%36.3 %35.1 %36.3 %34.4 %30.0 %33.8 %37.1 %
EBIT-%28.1 %26.1 %26.8 %26.0 %22.2 %13.1 %19.6 %
ROE27.5 %25.1 %25.8 %25.9 %21.2 %2.7 %5.4 %
ROI15.4 %13.8 %12.7 %13.2 %10.7 %2.0 %3.6 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.